
Broadening Biomarker Validation for Alzheimer’s Disease Diagnosis Globally
Traditional approaches for detecting Alzheimer’s disease (AD) that rely on examining the brain for amyloid plaques have limitations in accuracy and early detection. Although the industry has drastically evolved, these methods still require complex sample …